Lead Product(s) : ZLT-101
Therapeutic Area : Sleep
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Zelira Therapeutics Meets Primary Endpoints for Phase (1b/2a) Medicinal Cannabis Trial for Insomnia
Details : 23 chronic insomnia patients treated with ZLT-101, Zelira's proprietary and patented medicinal cannabis formulation, demonstrated statistically significant improvement in Insomnia Severity Index.
Product Name : ZLT-101
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 18, 2020
Lead Product(s) : ZLT-101
Therapeutic Area : Sleep
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable